Yield10 Bioscience Announces Participation at The H.C. Wainwright 22nd Annual Global Investment Conference on September 14-16, 2020 (Virtual Conference)
Yield10 Bioscience (NASDAQ: YTEN) will present at the H.C. Wainwright 22nd Annual Global Investment Conference from September 14-16, 2020. CEO Oliver Peoples will discuss the company's business strategy on September 14 at 11:00 am ET and will also participate in one-on-one investor meetings. Yield10 focuses on agricultural innovations, employing tools like the GRAIN gene discovery system, and aims to commercialize new traits for crops such as canola and soybean. The company is headquartered in Woburn, MA, with a center in Saskatoon, Canada.
- Participation in a prominent investment conference could enhance investor interest and visibility.
- Opportunity for one-on-one meetings with investors may lead to potential partnerships or investments.
- None.
WOBURN, Mass., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, today announced it will be featured as a presenting company at the H.C. Wainwright 22nd Annual Global Investment Conference. The conference is being held on September 14-16, 2020 virtually.
Oliver Peoples, Ph.D., President and Chief Executive Officer of Yield10, will provide an overview of the Company's business during the live presentation on Monday, September 14, 2020 at 11:00 am Eastern Time and will be available to participate in one-on-one meetings with investors who are registered to attend the conference.
If you are an institutional investor, and would like to attend the Company’s presentation, please click on the following link: www.hcwevents.com to register for the conference. Once your registration is confirmed, you will be prompted to log into the conference website to request a one-on-one meeting with the Company.
Event: H.C. Wainwright 22nd Annual Global Investment Conference (Virtual Conference)
Date: September 14, 2020
Time: 11:00 am Eastern Time
Location: Virtual Conference
Webcast URL: https://wsw.com/webcast/hcw7/yten/1628192
About Yield10 Bioscience
Yield10 Bioscience, Inc. is an agricultural bioscience company developing crop innovations for sustainable global food security. The Company uses its “Trait Factory” including the “GRAIN” big data mining trait gene discovery tool as well as the Camelina oilseed “Fast Field Testing” system to develop high value seed traits for the agriculture and food industries. As a path toward commercialization of novel traits, Yield10 is pursuing a partnering approach with major agricultural companies to drive new traits into development for canola, soybean, corn, and other commercial crops. The Company is also developing improved Camelina varieties as a platform crop for the production and commercialization of nutritional oils, proteins, and PHA biomaterials. The Company’s expertise in oilseed crops extends into canola, where it is currently field testing novel yield traits to generate trait performance data to drive additional licensing opportunities. Yield10 is headquartered in Woburn, MA and has an Oilseeds Center of Excellence in Saskatoon, Canada.
For more information about the Company, please visit the website and follow the Company on Twitter and LinkedIn. (YTEN-G)
Contacts:
Yield10 Bioscience:
Lynne H. Brum, (617) 682-4693, LBrum@yield10bio.com
Investor Relations:
Bret Shapiro, (561) 479-8566, brets@coreir.com
Managing Director, CORE IR
Media Inquiries:
Eric Fischgrund, eric@fischtankpr.com
FischTank PR
FAQ
When is Yield10 Bioscience presenting at the H.C. Wainwright Conference?
What is the focus of Yield10 Bioscience?
What tools does Yield10 use for crop innovation?
Where is Yield10 Bioscience headquartered?
What crops is Yield10 developing traits for?
